Rang	Name	Position
1	Dr. Peter P. Luo Ph.D.	Co- Founder, Chairman, CEO and President of R&D
2	Mr. Man Kin Tam M.B.A.	CFO & Director
3	Ms. Ling Zhou	Executive Director & Head of Human Resources
4	Dr. Qinghai Zhao Ph.D.	Chief Manufacturing Officer
5	Mr. Mickael Chane-Du	Chief Strategy Officer
6	Ms. Chunfang Gu	Executive Director of Finance
7	Ms. Yan Li M.B.A.	Senior Vice President of Bioinformatics & Information Technology
8	Ms. Xiaohong She	Senior VP & Head of Clinical Operations
9	Dr. Guizhong Liu Ph.D.	Senior Vice President of Early Drug Discovery
10	Mr. Alexander Goergen	VP & Head of Business Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	HSG Holding Ltd	0,00%	0,00 Mio. USD
2	Exome Asset Management LLC	0,00%	0,00 Mio. USD
3	Ameriprise Financial Inc	0,00%	0,00 Mio. USD
4	Mill Creek Capital Advisors LLC	0,00%	0,00 Mio. USD
5	Morgan Stanley - Brokerage Accounts	0,00%	0,00 Mio. USD
6	Amvescap Plc.	0,00%	0,00 Mio. USD
7	SmartHarvest Portfolios, LLC	0,00%	0,00 Mio. USD
8	Kamunting Street Cap Management, L.p.	0,00%	0,00 Mio. USD
9	Persistent Asset Partners Limited	0,00%	0,00 Mio. USD
10	Dauntless Investment Group, LLC	0,00%	0,00 Mio. USD
11	Renaissance Technologies Corp	0,00%	0,00 Mio. USD
12	Jane Street Group LLC	0,00%	0,00 Mio. USD
13	Alyeska Investment Group, L.P.	0,00%	0,00 Mio. USD
14	Royal Bank of Canada	0,00%	0,00 Mio. USD
15	Nomura Holdings Inc	0,00%	0,00 Mio. USD
16	Quadrature Capital Limited	0,00%	0,00 Mio. USD
17	Geode Capital Management, LLC	0,00%	0,00 Mio. USD
18	UBS Group AG	0,00%	0,00 Mio. USD
19	BNP Paribas Arbitrage, SA	0,00%	0,00 Mio. USD
20	EverSource Wealth Advisors, LLC	0,00%	0,00 Mio. USD